Brief: Alterity Therapeutics Announces 1-For-10 Reverse ADS Split
06/01/2023 06:46
Jan 6 (Reuters) - Alterity Therapeutics Ltd ATH.AX :
* ALTERITY THERAPEUTICS ANNOUNCES 1-FOR-10 REVERSE ADS SPLIT
* APPROVED A RATIO CHANGE OF ITS AMERICAN DEPOSITORY SHARES
TO
ORDINARY SHARES
* RATIO CHANGE TO 1 ADS REPRESENTING 600 ORDINARY SHARES
FROM
CURRENT RATIO OF 1 ADS REPRESENTING 60 ORDINARY SHARES
Source text for Eikon: ID:nASXMKrJW
Further company coverage: ATH.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alterity Therapeutics
See all newsBrief: Alterity Therapeutics Achieves Alignment With U.S. FDA On Pivotal Phase 3 Program For Ath434 In Multiple System Atrophy
Brief: Alterity Therapeutics Receives Positive FDA Feedback On Ath434 Phase 3 Program
Brief: Alterity Therapeutics Says Julian Barbaczy Appointed Non-Exec Chair
Brief: Alterity Therapeutics Raises A$20.0 Million In Strategic Placement
Brief: Alterity Therapeutics Ltd Raises A$20 Million In Capital